Adjuvant Chemotherapy for Stage II Right- and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data

PURPOSE: Survival benefit from adjuvant chemotherapy is established for stage III colon cancer; however, uncertainty exists for stage II patients. Tumor heterogeneity, specifically microsatellite instability (MSI) which is more common in right-sided cancers, may be the reason for this observation. W...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Weiss, Jennifer M., Schumacher, Jessica, Allen, Glenn O., Neuman, Heather, Lange, Erin O’Connor, LoConte, Noelle K., Greenberg, Caprice C., Smith, Maureen A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016118/
https://ncbi.nlm.nih.gov/pubmed/24643898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-3631-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados